We are live on ! Find out more
11A

10-15 Associates Portfolio holdings

AUM $516M
1-Year Est. Return 7.62%
This Fund
S&P 500
This Quarter Est. Return
+13.76%
1 Year Est. Return
+7.62%
3 Year Est. Return
+32.98%
5 Year Est. Return
+79.47%
10 Year Est. Return
AUM
$465M
AUM Growth
+$56.7M
Cap. Flow
+$7.41M
Cap. Flow %
1.59%
Top 10 Hldgs %
36.98%
Holding
107
New
15
Increased
33
Reduced
47
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 19.53%
2 Technology 17.58%
3 Financials 11.91%
4 Communication Services 9.61%
5 Consumer Staples 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
1
Verizon
VZ
$208B
$35.8M 7.7%
605,994
-332
-0.1% -$18.8K
SBUX icon
2
Starbucks
SBUX
$123B
$17.5M 3.76%
235,368
-5,839
-2% -$401K
PG icon
3
Procter & Gamble
PG
$334B
$17M 3.65%
163,248
-6,192
-4% -$603K
JNJ icon
4
Johnson & Johnson
JNJ
$646B
$15.7M 3.37%
112,201
+881
+0.8% +$118K
INTC icon
5
Intel
INTC
$473B
$15.6M 3.35%
290,342
+10,337
+4% +$524K
PFE icon
6
Pfizer
PFE
$159B
$14.8M 3.17%
366,320
+4,549
+1% +$182K
CSCO icon
7
Cisco
CSCO
$433B
$14.7M 3.17%
273,165
-14,181
-5% -$689K
JPM icon
8
JPMorgan Chase
JPM
$951B
$14M 3.01%
138,271
-239
-0.2% -$24.6K
MSFT icon
9
Microsoft
MSFT
$3.81T
$13.7M 2.95%
116,449
+4,947
+4% +$540K
RDS.B
10
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$13.3M 2.86%
208,285
+7,467
+4% +$472K
MRK icon
11
Merck
MRK
$366B
$12.9M 2.77%
162,530
+6,376
+4% +$477K
GSK icon
12
GSK
GSK
$102B
$12.8M 2.75%
245,389
+6,923
+3% +$346K
BA icon
13
Boeing
BA
$166B
$12.6M 2.7%
32,938
-586
-2% -$226K
ELV icon
14
Elevance Health
ELV
$85.5B
$12.4M 2.67%
43,257
+480
+1% +$139K
GIS icon
15
General Mills
GIS
$22.2B
$12.4M 2.66%
239,688
+5,278
+2% +$239K
XLNX
16
DELISTED
Xilinx Inc
XLNX
$12.3M 2.64%
97,053
-75,865
-44% -$8.52M
ACN icon
17
Accenture
ACN
$116B
$11.3M 2.44%
64,445
+3,785
+6% +$595K
ABBV icon
18
AbbVie
ABBV
$451B
$11.3M 2.43%
140,370
+8,471
+6% +$693K
CB icon
19
Chubb
CB
$131B
$11M 2.36%
78,340
+2,480
+3% +$330K
UPS icon
20
United Parcel Service
UPS
$89.6B
$10.9M 2.33%
97,235
+2,908
+3% +$308K
KKR icon
21
KKR & Co
KKR
$97.6B
$10.7M 2.29%
454,688
+14,881
+3% +$339K
CL icon
22
Colgate-Palmolive
CL
$72.3B
$10.5M 2.26%
+153,638
New +$9.92M
PNC icon
23
PNC Financial Services
PNC
$96.6B
$10.5M 2.25%
85,515
-993
-1% -$123K
EPD icon
24
Enterprise Products Partners
EPD
$84.3B
$10.1M 2.17%
347,758
+4,144
+1% +$116K
MPC icon
25
Marathon Petroleum
MPC
$104B
$10M 2.15%
+167,490
New +$10.5M

Similar funds

10-15 Associates's Q1 2019 Portfolio in Review

As of Q1 2019, 10-15 Associates held 107 positions worth $465M, up 14% from $409M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

10-15 Associates's Q1 2019 filing shows 15 new, 33 increased, 47 reduced and 9 closed positions. Its largest new stake was Marathon Petroleum: 167,490 shares worth $10M. The largest sale was Rio Tinto, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

  • 10-15 Associates's largest Q1 2019 buy was Marathon Petroleum: 167,490 shares worth $10M.
  • 10-15 Associates added most to ProShares S&P 500 Dividend Aristocrats ETF in Q1 2019, an estimated $2.32M increase.
  • 10-15 Associates's biggest Q1 2019 reduction was Xilinx Inc, cutting an estimated $8.52M.
  • 10-15 Associates fully exited Rio Tinto in Q1 2019, selling an estimated $10.2M.
  • 10-15 Associates's ten largest holdings make up 37% of its $465M portfolio in Q1 2019.
  • 10-15 Associates opened 15 new positions and closed 9 in Q1 2019.
  • 10-15 Associates's portfolio value rose 14% quarter-over-quarter to $465M.

Based on 10-15 Associates's 13F filing for Q1 2019, filed 9 May 2019.